New plant cleared trial, commercial output due within 5-7 days
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts more than Nifty Microcap 250 and 0.8 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Ajooni Biotech said its new plant completed a successful trial run and met all performance parameters. Commercial production is planned within 5-7 days. The facility adds 120,000 metric tons of annual capacity, lifting total capacity to 180,000 metric tons. The company expects better efficiency, lower costs and improved margins.
The 67% capacity increase may support revenue and margins if production ramps up as planned; execution and demand remain key.